Amrutanjan Health Care Limited

As of June 30, 2026, Amrutanjan Health Care Limited carries a market capitalization of 15.75B, placing it among publicly traded companies globally. Its enterprise value stands at 15.75B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Amrutanjan Health Care Limited has 28.90M shares outstanding.

As of June 30, 2026, Amrutanjan Health Care Limited trades at a trailing price-to-earnings ratio of 29.19.

As of June 30, 2026, Amrutanjan Health Care Limited trades at an EV/EBITDA multiple of 25.16 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.08 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 28.18 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 15.75B versus a market cap of 15.75B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 4.12M in revenue per employee across its workforce of 1,242.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Amrutanjan Health Care Limited recorded 186.92M in income tax expense. That works out to an effective tax rate of 25.72, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 726.65M, leaving 539.72M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Amrutanjan Health Care Limited's stock has declined approximately 31.90% over the past 52 weeks. The 50-day moving average sits at 504.69, while the 200-day moving average is 548.41.

Over the twelve months ended June 30, 2026, Amrutanjan Health Care Limited generated 5.11B in revenue and converted that into 539.72M in net income, yielding earnings per share of 18.67. EBITDA reached 625.94M, while operating income came in at 571.42M.

Over the twelve months ended June 30, 2026, Amrutanjan Health Care Limited posted a gross margin of 51.27, reflecting its pricing power and cost economics. The operating margin of 11.17 and net profit margin of 10.55 provide insight into operational efficiency.

Amrutanjan Health Care Limited's most recent stock split took place on April 13, 2018 with a 1:2 split ratio.